Company Filing History:
4 out of 2,361 
1 out of 1 
2 out of 833,002 Years Active: 2009-2020
Title: Innovations in Cancer Treatment by Rajeshwari Mehta
Introduction
Rajeshwari Mehta is a prominent inventor based in Orland Park, Illinois. She has made significant contributions to the field of cancer treatment through her innovative research and development. With a total of seven patents to her name, Mehta's work focuses on utilizing cupredoxins for therapeutic applications.
Latest Patents
Among her latest patents, Mehta has developed compositions comprising cupredoxins for treating cancer. This invention discloses methods and materials for killing and/or inhibiting the growth of cancer cells via the preferential entry of a cytotoxic compound. The preferential entry is achieved through the use of protein transduction domains derived from cupredoxins, including the p18 and p28 truncations of azurin. Additionally, she has patented methods to treat cancer with cupredoxins, further emphasizing her commitment to advancing cancer therapies.
Career Highlights
Throughout her career, Rajeshwari Mehta has worked with esteemed institutions, including the University of Illinois. Her research has garnered attention for its potential impact on cancer treatment, showcasing her dedication to scientific innovation.
Collaborations
Mehta has collaborated with notable colleagues such as Craig Beattie and Tapas Das Gupta. These partnerships have contributed to her research and the development of her patented technologies.
Conclusion
Rajeshwari Mehta's innovative work in cancer treatment through the use of cupredoxins highlights her role as a leading inventor in the field. Her contributions continue to pave the way for advancements in therapeutic strategies against cancer.